Apr. 9 at 3:25 PM
$ANVS CEO states that she is finally "close to marketing" and that she has "the absolute the best ... drug" and other such outlandish statements to lure in others. This includes investors looking for a cure for loved ones.
Dr. Maccecchini does this casually and likely everywhere, which means that she will use these same claims in her attempt to secure a replacement CFO ... yet, again.
One of the most troubling patterns is Dr. Maccecchini’s consistent deflection of responsibility onto others—former CFOs, contractors, CROs, PR teams, and even patients—rather than accepting accountability as CEO. Examples to follow in my next posts ...
Former CFOs: #JeffreyMcGroarty #HenryHagopian #WilliamFricker #AndrewWalsh #MarkGuerin + #CFODive #MauraWebberSadovi
Let’s start with her own words, sent directly to me as a retail investor:
> “All our PR people missed everything, our scientists do not want to do it. Who do you suggest?”
> “It turns out that no matter who you want to hire, they need an inordinate amount of time before they are even remotely capable of understanding the subject matter.”
> “The only cook and bottle washer at the company is me… I have given your emails to 3 people… they did absolutely nothing.”
> “Another thing you want to stay away from is employee comments.” (It isn't me. It is Dr. Maccecchini who is making derogatory statements about her own team member. She has done this for years.)
These are not statements from critics—these are her own admissions.
They reveal a CEO who:
* Dismisses and undermines her own team
* Publicly and privately shifts blame to others
* Minimizes the capabilities of professionals she hired
* Engages directly with retail investors in ways that raise serious governance concerns
This has serious downstream consequences.
**Reputational Damage to Others**
When a CEO repeatedly blames:
* Former CFOs
* Clinical Research Organizations (CROs)
* Public relations firms
* External contractors
…it doesn’t just deflect accountability—it actively damages the reputations of those organizations and individuals.
These are professionals whose careers depend on credibility. Casual or repeated negative assertions—especially coming from a CEO—can create lasting reputational harm, whether stated publicly or in private communications that circulate.
**Blaming Patients Is a Red Line**
Perhaps most concerning is her willingness to blame patients involved in Annovis’ clinical trials.
Clinical trial design—including patient selection criteria—is the responsibility of leadership and the scientific team. Dr. Maccecchini frequently emphasizes her deep experience in drug R&D. That makes the deflection even more problematic:
You cannot claim expertise while simultaneously blaming trial participants for outcomes tied to protocol design.
**The Live Patient Event Concern**
Equally troubling was the use of an Annovis “Live Patients” event where patients and their families were encouraged—directly or indirectly—to buy company stock.
Blurring the line between patient advocacy and investor solicitation is, at best, inappropriate—and at worst, a serious ethical and regulatory concern.
**Bottom Line**
A CEO sets the tone for accountability, professionalism, and integrity.
In this case, the pattern is clear:
* Blame others
* Undermine colleagues
* Deflect responsibility
* Engage in questionable investor communications
For me, that combination makes trust impossible.
Investors should pay close attention—not just to clinical data, but to leadership behavior.
---
Over time, I’ve reached a firm conclusion: leadership credibility matters—and in this case, it’s deeply compromised.
I am tagging
$AVXL $CGTX $BIVI $COYA as their are investors in those stocks who have invested for a cure ❤️
This series of posts this morning can be used to compare your company's management. Be glad if you appreciate the earnest work of the company or companies in this neurodegenerative space and share this cautionary information with others.
Coverage: #StatNews #AdamFeuerstein #StephenSedgwickCNBC #BrooklinCapitalMarkets #CharlesPiller
#ENDALZ #FDA_Drug_Info #GoTeamFox #Parkinsons #Research #FindACure #UnityWalk #OutrunPD #NIH #NIA #SEC
